Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer

INTRODUCTION: Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer with no effective targeted therapy. Inducible nitric oxide synthase (iNOS) is associated with poor survival in patients with breast cancer by increasing tumor aggressiveness. This work aimed to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Granados-Principal, Sergio, Liu, Yi, Guevara, Maria L, Blanco, Elvin, Choi, Dong Soon, Qian, Wei, Patel, Tejal, Rodriguez, Angel A, Cusimano, Joseph, Weiss, Heidi L, Zhao, Hong, Landis, Melissa D, Dave, Bhuvanesh, Gross, Steven S, Chang, Jenny C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384389/
https://www.ncbi.nlm.nih.gov/pubmed/25849745
http://dx.doi.org/10.1186/s13058-015-0527-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384389/
https://www.ncbi.nlm.nih.gov/pubmed/25849745
http://dx.doi.org/10.1186/s13058-015-0527-x

Ejemplares similares